The Brutalist Report

MarketWatch

• Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy. [47d]
• The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio [47d]
• The blowout jobs report is bad news for stocks — but it shouldn’t force the Fed’s hand on interest rates [47d]
• Can SpaceX live up to Wall Street’s multitrillion-dollar hype? [47d]
• America’s crude inventories are getting perilously low. But that’s not the full story. [48d]
• Apple’s WWDC will be a make-or-break moment for the company’s fledgling AI strategy [48d]
• The key to the upcoming Fed meeting? How Warsh reacts to all the hints of a rate hike. [48d]
• ‘He’s very short-tempered’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable? [48d]